NCT03697226 2021-01-13
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection.
Antiva Biosciences
Phase 1 Completed
Clinical Trials
5 trialsNCT03239223 2019-07-10
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
Antiva Biosciences
Phase 1 Completed
NCT01634503 2014-02-17
CIN3
Genexine, Inc.
Phase 1 Completed
NCT01880411 2013-06-19
Phase I, Open-Label Study of the Safety, Tolerability, and Immunogenicity PEK Fusion Protein Vaccine
HealthBanks Biotech Co., Ltd.
Phase 1 Unknown
NCT00989443 2010-10-21
Safety and Tolerability of Cidofovir Gel Applied on Cervix Squamous Lesions
Mithra Pharmaceuticals
Phase 1 Completed